Research ArticleArticle
BET Bromodomain Proteins Mediate Downstream Signaling Events following Growth Factor Stimulation in Human Lung Fibroblasts and Are Involved in Bleomycin-Induced Pulmonary Fibrosis
Xiaoyan Tang, Ruoqi Peng, Yonglin Ren, Subramanium Apparsundaram, Jeremy Deguzman, Carla M. Bauer, Ann F. Hoffman, Shannon Hamilton, Zhenmin Liang, Hang Zeng, Maria E. Fuentes, Julie A. DeMartino, Christopher Kitson, Christopher S. Stevenson and David C. Budd
Molecular Pharmacology January 2013, 83 (1) 283-293; DOI: https://doi.org/10.1124/mol.112.081661
Xiaoyan Tang
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Ruoqi Peng
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Yonglin Ren
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Subramanium Apparsundaram
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Jeremy Deguzman
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Carla M. Bauer
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Ann F. Hoffman
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Shannon Hamilton
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Zhenmin Liang
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Hang Zeng
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Maria E. Fuentes
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Julie A. DeMartino
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Christopher Kitson
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
Christopher S. Stevenson
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey
David C. Budd
Inflammation Discovery Therapeutic Area (X.T., R.P., Y.R., S.A., J.D., C.M.B., M.E.F., J.A.D., C.K., C.S.S., D.C.B.); Early ADME (DMPK) (Z.L., H.Z.); RDT–Discovery Technologies (A.F.H., S.H.); Hoffmann-La Roche Inc., Nutley, New Jersey

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Brd Proteins Mediate Lung Fibrosis
Xiaoyan Tang, Ruoqi Peng, Yonglin Ren, Subramanium Apparsundaram, Jeremy Deguzman, Carla M. Bauer, Ann F. Hoffman, Shannon Hamilton, Zhenmin Liang, Hang Zeng, Maria E. Fuentes, Julie A. DeMartino, Christopher Kitson, Christopher S. Stevenson and David C. Budd
Molecular Pharmacology January 1, 2013, 83 (1) 283-293; DOI: https://doi.org/10.1124/mol.112.081661
Research ArticleArticle
Brd Proteins Mediate Lung Fibrosis
Xiaoyan Tang, Ruoqi Peng, Yonglin Ren, Subramanium Apparsundaram, Jeremy Deguzman, Carla M. Bauer, Ann F. Hoffman, Shannon Hamilton, Zhenmin Liang, Hang Zeng, Maria E. Fuentes, Julie A. DeMartino, Christopher Kitson, Christopher S. Stevenson and David C. Budd
Molecular Pharmacology January 1, 2013, 83 (1) 283-293; DOI: https://doi.org/10.1124/mol.112.081661
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement